Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties
Nathan Riguet, Anne‐Laure Mahul‐Mellier, Niran Maharjan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
Philip Stavrides, Chris N. Goulbourne, James Peddy, et al.
(2025)
Open Access | Times Cited: 1
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
Gaetano Calabrese, Cristen Molzahn, Thibault Mayor
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102062-102062
Open Access | Times Cited: 61
The structure of pathogenic huntingtin exon 1 defines the bases of its aggregation propensity
Carlos A. Elena‐Real, Amin Sagar, Annika Urbanek, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 3, pp. 309-320
Open Access | Times Cited: 33
Advanced Techniques for Detecting Protein Misfolding and Aggregation in Cellular Environments
Yulong Bai, Shengnan Zhang, Hui Dong, et al.
Chemical Reviews (2023) Vol. 123, Iss. 21, pp. 12254-12311
Closed Access | Times Cited: 23
Label-Free Techniques for Probing Biomolecular Condensates
Khalid A. Ibrahim, Akhil S. Naidu, Helena Miljkovic, et al.
ACS Nano (2024) Vol. 18, Iss. 16, pp. 10738-10757
Closed Access | Times Cited: 10
Structural Basis of Huntingtin Fibril Polymorphism Revealed by Cryogenic Electron Microscopy of Exon 1 HTT Fibrils
Sergey Nazarov, Anass Chiki, Driss Boudeffa, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 24, pp. 10723-10735
Closed Access | Times Cited: 29
Pathobiology of the autophagy-lysosomal pathway in the Huntington’s disease brain
Martin J. Berg, Veeranna, Corrinne M. Rosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
Mauro Montalbano, Lajja Majmundar, Urmi Sengupta, et al.
Brain Pathology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 24
Boosting mitochondrial health to counteract neurodegeneration
Johannes Burtscher, Mario Romani, Greta Bernardo, et al.
Progress in Neurobiology (2022) Vol. 215, pp. 102289-102289
Open Access | Times Cited: 23
Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1
Nitin Pandey, Jobin Varkey, Anakha Ajayan, et al.
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105585-105585
Open Access | Times Cited: 13
Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts
Tim E. Moors, Dragomir Milovanović
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 17-33
Open Access | Times Cited: 4
Structural Mapping of Protein Aggregates in Live Cells Modeling Huntington’s Disease
Zhongyue Guo, Giulio Chiesa, Jiaze Yin, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 35
Closed Access | Times Cited: 4
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
Hyun-Ju Cho
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access
Omics studies of nuclear protein aggregates in subcellular fractions reveals co- aggregation of RNA-binding proteins affecting cytosolic pathways
Milad Shademan, Sarah Flannery, Erik Bos, et al.
Research Square (Research Square) (2025)
Closed Access
Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin
Jeong Hyun Oh, Christy Catherine, Eun Seon Kim, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
Philip Stavrides, Chris N. Goulbourne, James Peddy, et al.
(2025)
Open Access
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
Taylor R. Church, Seth S. Margolis
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Implications of Mutant SOD1 on RNA Processing and Interferon Responses in Amyotrophic Lateral Sclerosis: Omics Data Analysis
Naoto Honda, Yasuhiro Watanabe, Hiroki Honda, et al.
Cureus (2025)
Open Access
To target Tau pathologies, we must embrace and reconstruct their complexities
Galina Limorenko, Hilal A. Lashuel
Neurobiology of Disease (2021) Vol. 161, pp. 105536-105536
Open Access | Times Cited: 28
Model biomolecular condensates have heterogeneous structure quantitatively dependent on the interaction profile of their constituent macromolecules
Julian C. Shillcock, Clément Lagisquet, Jérémy Alexandre, et al.
Soft Matter (2022) Vol. 18, Iss. 35, pp. 6674-6693
Open Access | Times Cited: 21
Ubiquitin-modifying enzymes in Huntington’s disease
Karen A. Sap, Karlijne W. Geijtenbeek, Sabine Schipper-Krom, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
Sphingolipids and impaired hypoxic stress responses in Huntington disease
Johannes Burtscher, Giuseppe Pepe, Niran Maharjan, et al.
Progress in Lipid Research (2023) Vol. 90, pp. 101224-101224
Open Access | Times Cited: 10
Subcellular localization and ER-mediated cytotoxic function of α1A and α1ACT in spinocerebellar ataxia type 6
Di Wang, Shinya Honda, Min Kyoung Shin, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 695, pp. 149481-149481
Closed Access | Times Cited: 3
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases
Jun Liu, M. Maral Mouradian
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2364-2364
Open Access | Times Cited: 3
Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model
Abuelnor Mohammed, Azza Ramadan, Asim Ahmed Elnour, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 9
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top